Navigation Links
MedCom Announces Card Activation Wins Significant Court Ruling
Date:3/25/2008

d Activation Technologies go to http://www.cardactivation.com .

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Card Activation Technologies, Inc. (the Company) to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) defend its patent; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission, which are available for review at http://www.sec.gov under "Search for Company Filings."

Contact for MedCom USA, Inc.

Kent Barghols

Ph. 515-276-1180


'/>"/>
SOURCE MedCom USA, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
2. MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System
3. MedcomSoft Receives 2007s "Best in KLAS" EMR Ranking (1-5 Physicians)
4. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
5. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
6. Tempo Participacoes S.A. Announces Increase of 16.8% in Net Revenue and of 46.3% in EBITDA for 2007
7. Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007
8. Health Fitness Announces $2.5 Million Stock Repurchase Plan
9. Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations
10. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
11. Olympus Announces 2008 Winners of Olympus Innovation Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)... MOUNTAIN VIEW, Calif., May 15 /PRNewswire-FirstC...A ) announced today that Carlos A. Parra,has joine...have,responsibilities in the development and execu...nufacturing operations and preclinical / clinical,...ce President, Operations,and Quality at Telik, Inc...
(Date:5/15/2008)... VANCOUVER, May 15 /PRNewswire-FirstCall/ - QLT I...it has signed a sale and purchase agreement to,sel...eadquarters and an,adjacent undeveloped parcel of ...th the closing of the transaction, QLT will enter ... continue its operations., "We are very pleased t...
(Date:5/15/2008)... Sees Improvement But is Concerned About Loss of ...ewswire-USNewswire/ -- A settlement,with Kaiser Pe...h coverage,was retroactively cancelled is an impro...hat patients can make claims for repayment of loss...kruptcy or loss of a home.,In past proposals patie...
(Date:5/15/2008)... OAKLAND, Calif., May 15 /PRNewswire-FirstCall/ -... (the "Company") today announced that, on May,12, ... Letter stating that,the Company,s requests for co...een denied. The NASDAQ noted that the Company did ...ty to achieve near term compliance with,the contin...
Breaking Medicine News(10 mins):Health News:Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality 2Health News:QLT Inc. announces agreement for sale of real estate 2Health News:QLT Inc. announces agreement for sale of real estate 3Health News:Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser 2Health News:Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser 3Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 2Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 3
...g pioneer of South Korea is defending his embattle...rs of Science magazine in Washington to retract hi...magazine, Donald Kennedy said that Hwang would hav.... months' to explain and support his bid to retrac...
...e Chancellor of James Cook University's (JCU) has ...the medical seats in the University which will hel...the occasion of its graduation day.// James Cook U...ity which is leading internationally in teaching a...
...dren's Fund has been launched in Singapore by Bala...lth. The object of the fund is to help the women a...treatment they require.// The KK Women's and Child...he Fund, which has over US$ 200,000 already. As ...
...now think that no special detergents is required ...sly it was recommended that one use phosphate dete...rs at the Saint Louis University School of Public ...p all-purpose detergents are enough to remove lead...
Other Medicine News:Health News:Scientist Calls Upon Media To Retract His Work 2
(Date:5/15/2008)...EEN BAY, Wis., May 15 /- Omega 3 fatt...her considered as a credible natural,alternative a...HD patients,recent in vivo French study reveals. ...ects of omega-3 in hyperactivity, French researche...specific positive effects on,impulse control., Th...
(Date:5/14/2008)...elieved by experts to be important for cervical ca...e-FirstCall/ -- New data from an,extended follow-u...rvical,cancer candidate vaccine, CERVARIX(R) gener...ies against the two most common cervical cancer-ca...rs. This is the longest,duration of sustained neut...
(Date:5/14/2008)...essful Collaboration with Scripps Florida and Scri... Jolla-, SOUTH SAN FRANCISCO, Calif., and LA JOLL...rd Pharmaceuticals, Inc. (Nasdaq: PARD ), a,bioph...Scripps Research,Institute, a non-profit biomedica...greement has been executed licensing classes of pr...
(Date:5/14/2008)...YLESTOWN, Pa., May 14 /- Th...ositive results from a study,conducted by its whol...s,conducted in chickens to evaluate the anti-viral...as administered to chicks that had been infected,w...om the study indicated,that QR448(a) is efficaciou...
Breaking Medicine Technology:Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 2CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 4CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 5CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 6Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 1China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 2China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 3China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 4China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 5China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results 12329 6Derma Sciences Announces Several Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming APWCA Conference 12326 1Derma Sciences Announces Several Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming APWCA Conference 12326 2Derma Sciences Announces Several Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming APWCA Conference 12326 3Derma Sciences Announces Several Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming APWCA Conference 12326 4CryoCath Technologies notice of annual meeting 12323 1New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3410 1New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3410 2New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3410 3
...)--Mar 15, 2007 - Gilead,Sciences, Inc. (Nasdaq:GI...data on a novel nucleotide analog, GS 9219, which ...linical studies, at the,2007 Annual Meeting of the...which will take place in Los Angeles on April 14-1...urrently focused on,oncology, GS 9219 emerged from...
... today announced that its,collaboration partner At...ults from the ARISE (Aggressive Reduction of Infla...trial which studied,AGI-1067, an investigational a...i-inflammatory effects, in patients with,coronary ...t its primary endpoint of a,statistically signific...
Other Medicine Technology:Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 2Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219,to be Presented at AACR 3Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet,Primary Endpoint 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: